These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 228883)

  • 1. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
    Remold HG; Mednis AD
    J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on guinea-pig macrophage migration inhibitory factor (MIF). II. Purification of MIF after treatment with reducing and denaturing agents.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):540-50. PubMed ID: 389497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on human migration inhibitory factor: characterization of three molecular species.
    Weiser WY; Greineder DK; Remold HG; David JR
    J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
    J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
    Fahlbusch B; Zschiesche W
    Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of murine migration inhibitory factor (MIF).
    Kühner AL; David JR
    J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical properties of antigen-dependent migration inhibition factor in mice.
    Krejci J; Pekarek J; Rozprimova L; Svejcar J; Johanovsky J
    Immunology; 1976 Aug; 31(2):283-6. PubMed ID: 783044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor.
    Pick E; Godny Y; Gold EF
    Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
    Fahlbusch B; Metzner G; Schumann I; Tittel R
    Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Oki S; Hirose S; Higuchi M; Osawa T
    Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of tilorone-induced mouse migration inhibitory factor by affinity chromatography and isoelectric focusing.
    Fahlbusch B; Zschiesche W; Römer W
    Acta Biol Med Ger; 1981; 40(2):147-52. PubMed ID: 7023160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.